Bacteroides–Escherichia interactions contribute to colonization resistance against Clostridioides difficile
Abstract
Commensal gut bacteria are key contributors to the resilience against pathogen invasion. This is exemplified by the success of faecal microbiota transplantation in treating recurrent Clostridioides difficile infection. Yet, characteristics of communities that can confer colonisation resistance and the underlying mechanisms remain largely unknown. Here we use a synthetic community of 14 commensal gut bacteria to uncover inter-species interactions and metabolic pathways underpinning the emergent resilience against C. difficile invasion. We challenged this synthetic community as well as faecal-matter-derived communities with antibiotic treatment and C. difficile in a continuous flow bioreactor. Using generalised Lotka-Volterra and genome-scale metabolic modelling, we identified interactions between Escherichia coli and Bacteroides/Phocaeicola sp. as key to the pathogen’s suppression. Metabolomics and targeted validation experiments revealed that fructan-derived fructooligosaccharides, vitamin B3 biosynthesis, and competition for Stickland metabolism precursors causally contribute to suppression across multiple C. difficile strains and donor backgrounds. Analysis of metagenomics data from patient cohorts and clinical trials attested the in vivo relevance of the identified metabolic pathways and the ratio between Bacteroides and Escherichia in successful colonisation resistance. The latter was found to be a stronger discriminator than commonly used alpha diversity metrics. Together, our study uncovers emergent microbial interactions in pathogen resistance with implications for rational design of bacteriotherapies.
Related
- Microbial communication networks governing the ecosystem dynamics of Salmonella in poultry environments: ecological interactions, colonization resistance, and emerging control strategies
- Disentangling polymer confinement from specific-folding interactions reveals the drivers of Escherichia coli chromosome organization
- A phospholipase B effector exploits membrane lipid divergence to drive inter-Bacteroides competition and enables universal genome editing.
- Bacteroides fragilis toxin (BFT) detection and neutralization using phage display-derived synthetic hagfish VLRBs
- Systemically delivered Bacteroides thetaiotaomicron-derived bacterial extracellular vesicles inhibit primary and metastatic melanoma growth
BibTeX
@article{ambat2026bacteroidesescherichia,
title = {{Bacteroides–Escherichia interactions contribute to colonization resistance against Clostridioides difficile}},
author = {Achuthan Ambat and Naomi Iris van den Berg and Francisco Zorrilla and Shruti Menon and Abhijit Maji and Tanim Islam and Arianna Basile and Sudeep Ghimire and Lajos Kalmar and Kiran R. Patil and Joy Scaria},
journal = {Nature Communications},
year = {2026},
month = oct,
doi = {10.1038/s41467-026-78132-5},
url = {https://www.nature.com/articles/s41467-026-78132-5},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Bacteroides–Escherichia interactions contribute to colonization resistance against Clostridioides difficile
AU - Achuthan Ambat
AU - Naomi Iris van den Berg
AU - Francisco Zorrilla
AU - Shruti Menon
AU - Abhijit Maji
AU - Tanim Islam
AU - Arianna Basile
AU - Sudeep Ghimire
AU - Lajos Kalmar
AU - Kiran R. Patil
AU - Joy Scaria
PY - 2026
DA - 2026/10/18
JO - Nature Communications
DO - 10.1038/s41467-026-78132-5
UR - https://www.nature.com/articles/s41467-026-78132-5
AB - Commensal gut bacteria are key contributors to the resilience against pathogen invasion. This is exemplified by the success of faecal microbiota transplantation in treating recurrent Clostridioides difficile infection. Yet, characteristics of communities that can confer colonisation resistance and the underlying mechanisms remain largely unknown. Here we use a synthetic community of 14 commensal gut bacteria to uncover inter-species interactions and metabolic pathways underpinning the emergent resilience against C. difficile invasion. We challenged this synthetic community as well as faecal-matter-derived communities with antibiotic treatment and C. difficile in a continuous flow bioreactor. Using generalised Lotka-Volterra and genome-scale metabolic modelling, we identified interactions between Escherichia coli and Bacteroides/Phocaeicola sp. as key to the pathogen’s suppression. Metabolomics and targeted validation experiments revealed that fructan-derived fructooligosaccharides, vitamin B3 biosynthesis, and competition for Stickland metabolism precursors causally contribute to suppression across multiple C. difficile strains and donor backgrounds. Analysis of metagenomics data from patient cohorts and clinical trials attested the in vivo relevance of the identified metabolic pathways and the ratio between Bacteroides and Escherichia in successful colonisation resistance. The latter was found to be a stronger discriminator than commonly used alpha diversity metrics. Together, our study uncovers emergent microbial interactions in pathogen resistance with implications for rational design of bacteriotherapies.
SN - 2041-1723
ER -